Gynakologie is a specialized academic journal published by Springer Heidelberg, focusing on the dynamic field of obstetrics and gynecology. With an ISSN of 2731-7102 and an E-ISSN of 2731-7110, the journal aims to provide a platform for innovative research and discussions that contribute significantly to women's health. Launched in 2022 and set to converge by 2024, it has quickly established itself within the academic community, currently ranking in the Q4 category in Obstetrics and Gynecology as per the 2023 quartile assessments. Despite its current positioning, the journal is dedicated to enhancing visibility and scholarly impact in this essential medical field. Published in Germany, it plays an important role in disseminating valuable insights and findings among researchers, clinicians, and students alike, thus fostering a better understanding of women's health issues. While the journal currently lacks open access options, it remains committed to contributing to the body of knowledge and advancing practices that benefit patients worldwide.

ACTA Obstetricia et Gynecologica Scandinavica, published by Wiley, is a leading journal in the fields of obstetrics and gynecology, with its impressive history dating back to 1921. This esteemed journal holds a prestigious Q1 ranking in both Medicine (miscellaneous) and Obstetrics and Gynecology, positioning it in the top percentile of global research outputs according to Scopus. With an exceptionally high percentiles rank, #16 out of 209, it serves as a vital platform for researchers, practitioners, and students eager to contribute to and gain insights from cutting-edge studies impacting women's health. Although it does not currently provide open-access options, the journal’s rigorous peer-review process ensures that high-standard research reaches its diverse audience. By converging years of knowledge towards 2024, ACTA Obstetricia et Gynecologica Scandinavica continues to be essential in discussing contemporary issues and advancements in reproductive health, fostering significant scientific discourse and innovation.

Gynecologie Obstetrique Fertilite & Senologie, published by ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, serves as a crucial resource for researchers and practitioners in the fields of obstetrics, gynecology, and reproductive medicine. Established in 2017 and continuing through 2024, this journal provides a platform for the dissemination of impactful research, evidenced by its placement in the Q3 category for both obstetrics and gynecology and reproductive medicine in 2023. Although it currently does not operate under an open-access model, the journal is committed to advancing knowledge and practice in women's health and reproductive issues, ensuring that professionals stay at the forefront of scientific developments. With an ISSN of 2468-7197 and an E-ISSN of 2468-7189, the journal not only supports the global medical community from its base in France but also contributes to the broader academic discourse on critical topics such as fertility and women's health. As researchers and professionals in the field seek to enhance their understanding and impact, Gynecologie Obstetrique Fertilite & Senologie remains an essential publication for quality research and innovative solutions in women’s health.

CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, is an esteemed academic journal that has been providing critical insights and reviews in the fields of Obstetrics and Gynecology since its inception in 1989. With an ISSN of 1040-872X and an E-ISSN of 1473-656X, this journal plays a vital role in disseminating impactful research findings, clinical practices, and emerging trends in women's health. As a recognized entity in the medical community, it proudly ranks in the second quartile (Q2) across both Medicine (miscellaneous) and Obstetrics and Gynecology categories, underscoring its significance in shaping contemporary discourse. With an impressive Scopus ranking of #69 out of 209 in its field, it reflects a strong commitment to relevance and excellence in research. Although currently not offering open access, it remains a crucial platform for researchers, healthcare professionals, and students seeking to enhance their understanding and practice in obstetrics and gynecology. The journal’s ongoing evolution through to 2024 ensures that it will continue to be at the forefront of scientific advancement and clinical guidelines in women's health.

CLINICAL OBSTETRICS AND GYNECOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, stands as a pivotal journal in the field of obstetrics and gynecology, boasting a rich history since its inception in 1958. With its ISSN 0009-9201 and E-ISSN 1532-5520, the journal serves as a critical repository of contemporary research and clinical advancements, providing invaluable insights to healthcare professionals and researchers. As a prominent Q2 ranked journal in the Obstetrics and Gynecology category, it is recognized for its impactful contributions to medical practice and education, holding a respectable Scopus rank of #103 out of 209, placing it in the 50th percentile. While not an open-access journal, it ensures wide dissemination of knowledge through institutional subscriptions, enhancing the accessibility of its peer-reviewed content. The scope of the journal encompasses a diverse range of topics vital to the ongoing evolution of women's health, making it an essential resource for those dedicated to fostering clinical excellence and advancing research in obstetrics and gynecology.

Obstetrics and Gynecology is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the comprehensive fields of obstetrics and gynecology. With an impressive impact factor and a prestigious ranking of Q1 in Obstetrics and Gynecology as of 2023, this journal is recognized for its significant contributions, placing it in the top tier among its peers (6th out of 209 in Scopus' Medicine category). Established in 1953, it continues to publish high-quality research and clinical studies that advance the field. Although it is not open access, this journal is essential for practitioners, researchers, and academics who seek to stay updated on the latest advancements in women's health. Its commitment to disseminating vital information makes it an invaluable resource for those dedicated to improving patient outcomes and enhancing the understanding of gynecological and obstetric practices. The journal is based in the United States, at Two Commerce Sq, 2001 Market St, Philadelphia, PA 19103, and continues to lead discussions and innovations in women's healthcare.

The Journal of Obstetrics and Gynaecology Canada, published by Elsevier Inc., is a leading bi-monthly journal committed to advancing the fields of obstetrics and gynecology through high-quality research and clinical insights. With an impact factor positioned within the competitive Q2 category of the Obstetrics and Gynecology field as of 2023, this journal serves as a vital resource for researchers, clinicians, and students eager to stay informed about the latest developments. The journal is renowned for its rigorous peer-review process and dedication to disseminating innovative findings from 2002 to 2024. Currently ranked #92 out of 209 in Scopus' Medicine Obstetrics and Gynecology category, it falls within the 56th percentile of its peers. While it operates on a subscription basis, the contents are pivotal for professionals looking to enhance their practices and contribute to the ongoing discourse in maternal and women's health. For those dedicated to improving patient outcomes and advancing gynecological knowledge, the Journal of Obstetrics and Gynaecology Canada represents an invaluable platform.

Welcome to the Journal of Obstetrics and Gynaecology, a premier academic publication dedicated to advancing the field of obstetrics and gynecology. Published by Taylor & Francis Inc, this esteemed journal has been a vital resource since its inception in 1945, with a convergence period from 1980 to 2024. Now embracing the Open Access model since 2023, it aims to disseminate research more broadly, facilitating knowledge transfer among researchers, healthcare professionals, and students alike. With a current impact factor that situates it within the Q3 category of Obstetrics and Gynecology, the journal has garnered recognition as a significant contributor to the medical community, ranked #109 out of 209 in Scopus. Based in the United Kingdom, the journal focuses on publishing high-quality research that addresses contemporary issues in women's health, aiming to significantly enhance clinical practices and patient outcomes. Whether you are a seasoned researcher or a student venturing into the field, the Journal of Obstetrics and Gynaecology offers a wealth of knowledge, fostering innovation and excellence within this critical discipline.

Obstetrics and Gynecology International is a premier, peer-reviewed journal published by HINDAWI LTD, dedicated to advancing the fields of obstetrics and gynecology. With an open access model established in 2009, this journal ensures that research findings are freely accessible to all, significantly contributing to the global dialogue in women's health. As of 2023, the journal holds a respectable Q3 ranking in the Obstetrics and Gynecology category and is positioned in the 60th percentile among its peers in the Scopus indexing, highlighting its impact in the field. The journal addresses a broad spectrum of topics relevant to both clinical practitioners and researchers, fostering an interdisciplinary approach to maternal and reproductive health. With a commitment to the dissemination of innovative research and evidence-based practices, Obstetrics and Gynecology International serves as an essential resource for professionals eager to stay abreast of ongoing developments and enhance their understanding of complex issues in women's health.

Reproductive Health is a leading open-access journal published by BMC, dedicated to advancing knowledge in the fields of obstetrics, gynecology, and reproductive medicine. Established in 2004, the journal has made significant contributions to the global discourse on reproductive health practices and policies, garnering a prestigious Q1 rank in both the Obstetrics and Gynecology and Reproductive Medicine categories as of 2023. With a strong Scopus ranking of #36 out of 209 in Obstetrics and Gynecology and #20 out of 90 in Reproductive Medicine, it boasts an impressive reach and impact, ensuring that vital research is accessible to a wide audience. Reproductive Health aims to foster innovative research and practice, facilitating a deeper understanding of reproductive health issues that affect diverse populations. As an open-access journal, it ensures that all research outputs are freely available, promoting transparency and collaboration in the scientific community. Based in the United Kingdom, Reproductive Health is poised to continue its mission of enhancing reproductive health outcomes worldwide through rigorous research, clinical trials, and public health studies.